SYK
Stryker Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth +13.6% ·
share flow -1.6% ·
net new positions +8.0%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 172 | +2 | 222.54M | $70.41B | +7 | −4 |
| Q1 2026 | 172 | -2 | 215.42M | $70.87B | +1 | −4 |
| Q4 2025 | 173 | -1 | 229.53M | $80.67B | +1 | −1 |
| Q3 2025 | 25 | +3 | 142.80M | $52.79B | +4 | −2 |
| Q2 2025 | 20 | 0 | 117.11M | $46.33B | +1 | −1 |
| Q1 2025 | 17 | -2 | 51.08M | $19.01B | — | −2 |
| Q4 2024 | 19 | 0 | 52.07M | $18.75B | +1 | −1 |
| Q3 2024 | 18 | +2 | 39.19M | $14.15B | +2 | — |
| Q2 2024 | 16 | — | 41.27M | $14.03B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 33.77M | +0.8% | $12.49B | 0.2% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passive) | 26.73M | +0.4% | $9.88B | 0.2% | ▲ Add | 2 | SEC ↗ ×22 |
| 3 | JPMorgan Chase ✦ | 23.88M | — | $8.83B | 0.3% | n/c | 1 | SEC ↗ ×42 |
| 4 | State Street Global Advisors ✦ (passive) | 14.94M | -0.1% | $5.54B | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 11.00M | -7.6% | $4.07B | 0.4% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (passive) | 7.47M | +1.0% | $2.75B | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 6.46M | — | $2.39B | 0.1% | n/c | 1 | SEC ↗ ×20 |
| 8 | Wellington Management ✦ | 5.29M | -4.8% | $1.96B | 0.3% | ▼ Trim | 6 | SEC ↗ ×8 |
| 9 | Fidelity (FMR) ✦ | 5.14M | -28.1% | $1.90B | 0.1% | ▼ Trim | 2 | SEC ↗ ×7 |
| 10 | Fisher Asset Management ✦ | 3.31M | -4.1% | $1.22B | 0.4% | ▼ Trim | 6 | SEC ↗ |
| 11 | Goldman Sachs Group ✦ | 2.45M | — | $903.94M | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 12 | Two Sigma Investments ✦ | 554.35K | +15.4% | $204.93M | 0.3% | ▲ Add | 6 | SEC ↗ |
| 13 | PRIMECAP Management ✦ | 508.50K | +0.7% | $187.98M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 367.79K | New | $135.96M | 0.1% | New | 1 | SEC ↗ ×2 |
| 15 | Adage Capital Partners ✦ | 178.86K | -24.1% | $66.12M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 136.26K | +10.4% | $50.37M | 0.0% | ▲ Add | 6 | SEC ↗ ×6 |
| 17 | Millennium Management ✦ | 118.77K | +2617.8% | $43.90M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 116.65K | -71.9% | $43.12M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 19 | Marshall Wace ✦ | 109.43K | +1819.8% | $40.45M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 20 | Renaissance Technologies ✦ | 103.20K | New | $38.15M | 0.1% | New | 1 | SEC ↗ |
| 21 | Point72 Asset Management ✦ | 94.47K | New | $34.92M | 0.1% | New | 1 | SEC ↗ |
| 22 | Arrowstreet Capital ✦ | 22.47K | New | $8.31M | 0.0% | New | 1 | SEC ↗ |
| 23 | GAMCO Investors ✦ | 22.07K | -0.5% | $8.16M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 16.84K | +35.9% | $6.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | Bridgewater Associates ✦ | 12.10K | +2.0% | $4.47M | 0.0% | ▲ Add | 6 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Citadel Advisors | $135.96M | 0.1% |
| Renaissance Technologies | $38.15M | 0.1% |
| Point72 Asset Management | $34.92M | 0.1% |
| Arrowstreet Capital | $8.31M | 0.0% |
Exited
| Norges Bank | $1.88B | was 0.2% |
| Harris Associates (Oakmark) | $225,905 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2,274 holders, 283.44M shares, $87.41B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Director · 18 sh @ 225.19 · $4,054
Director · 3 sh @ 185.65 · $557
Director · 36 sh @ 193.21 · $6,956
Director · 11 sh @ 221.03 · $2,431
Director · 63 sh @ 202.21 · $12,739
Open-market sales (S)
Officer · 441 sh · $144,915
Director · 11.26K sh · $3.81M
Director · 40 sh · $13,272
Director · 440 sh · $146,598
Director · 200 sh · $66,786
Director · 80 sh · $26,804
Director · 320 sh · $107,774
Director · 2.31K sh · $780,062
Director · 10.81K sh · $3.67M
Director · 16.61K sh · $5.66M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology